- Home
- MSC vs LBPH Comparison
MSC vs LBPH Comparison
Compare MSC & LBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- LBPH
- Stock Information
- Founded
- MSC 2000
- LBPH 2020
- Country
- MSC Hong Kong
- LBPH United States
- Employees
- MSC N/A
- LBPH N/A
- Industry
- MSC Hotels/Resorts
- LBPH Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- LBPH Health Care
- Exchange
- MSC Nasdaq
- LBPH Nasdaq
- Market Cap
- MSC 1.2B
- LBPH 1.4B
- IPO Year
- MSC 2018
- LBPH 2021
- Fundamental
- Price
- MSC $6.22
- LBPH $59.69
- Analyst Decision
- MSC
- LBPH Buy
- Analyst Count
- MSC 0
- LBPH 8
- Target Price
- MSC N/A
- LBPH $52.29
- AVG Volume (30 Days)
- MSC 5.8K
- LBPH 1.1M
- Earning Date
- MSC 11-05-2024
- LBPH 11-07-2024
- Dividend Yield
- MSC N/A
- LBPH N/A
- EPS Growth
- MSC N/A
- LBPH N/A
- EPS
- MSC N/A
- LBPH N/A
- Revenue
- MSC $627,533,000.00
- LBPH N/A
- Revenue This Year
- MSC $33.86
- LBPH N/A
- Revenue Next Year
- MSC $16.73
- LBPH N/A
- P/E Ratio
- MSC N/A
- LBPH N/A
- Revenue Growth
- MSC 103.40
- LBPH N/A
- 52 Week Low
- MSC $4.32
- LBPH $3.60
- 52 Week High
- MSC $9.30
- LBPH $59.95
- Technical
- Relative Strength Index (RSI)
- MSC 44.80
- LBPH 79.25
- Support Level
- MSC $6.00
- LBPH $59.71
- Resistance Level
- MSC $7.18
- LBPH $59.87
- Average True Range (ATR)
- MSC 0.36
- LBPH 0.23
- MACD
- MSC 0.00
- LBPH -0.92
- Stochastic Oscillator
- MSC 18.64
- LBPH 76.99
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About LBPH Longboard Pharmaceuticals Inc.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.